Synapxe uses artificial intelligence to measure the risk of chronic kidney disease deterioration


Share this article

Synapxe uses artificial intelligence to measure the risk of chronic kidney disease deterioration

Senior Principal Specialist Dr. Goh Han Leong (left) and Principal Specialist Dr. Fu Zhiyan (right), as part of Synapxe’s Data aNalytics & Ai (DnA) team (Image credit: Chen Lai Fu)

There are more than 400,000 patients with diabetes in Singapore, and chronic kidney disease (CKD) is one of the most common complications. Synapxe, Singapore’s national healthtech agency under the Ministry of Health, has developed an artificial intelligence (AI) system to estimate the risk of worsening of chronic kidney disease in patients with diabetes in the next five years. This serves to help doctors better provide advice to patients, including early intervention treatment and disease control.

Diabetes is one of the common causes of CKD. CKD will gradually cause patients to lose kidney function, but its symptoms are not obvious in the early stages. Once CKD develops into end stage renal failure, dialysis or kidney transplantation is required to sustain life. Data shows that up to two-thirds of renal failure is caused by diabetes.

CKD is divided into five stages. The first nationwide CKD prediction model for diabetic patients developed by Synapxe uses data from patients with stage 1 and 2 CKD in the national diabetes database. It analyses whether these patients would progress to stage 3 and above, with more serious conditions, in the future.

The AI prediction model will analyse various data, including the patient's age, sex, medication records and blood test results, and classify the patient into 3 categories – namely low risk, high risk, and extremely high risk.

Dr. Fu Zhiyan, Principal Specialist at Synapxe’s Data aNalytics & Ai (DnA) team, said during the interview that the prediction model has been integrated into the National Electronic Health Record (NEHR). Doctors can view their patient's risk category from the system and provide further advice. Generally, low-risk patients only need to be continuously monitored. Dr. Goh Han Leong, Senior Principal Specialist at Synapxe’s DnA team, highlighted that in the process of data collection and model design, they communicated with clinicians consistently to obtain feedback and improved the model. This is to ensure that the model can be used effectively as "gaining the confidence of doctors is crucial". 

According to both specialists involved in the study, this research aims to aid doctors with making medical decisions. Data has shown that early intervention in medical treatment can help to slow down the deterioration of CKD in patients.

The clinical model, which has been endorsed by the Ministry of Health (MOH), is part of Singapore’s Holistic Approach in Lowering and Tracking Chronic Kidney Disease (HALT-CKD) programme.

In 2017, MOH launched a comprehensive programme to delay kidney disease. Through methods such as conducting kidney function tests and consuming drugs to protect kidney function, it allows patients with proper illness management to slow down the deterioration of CKD and reduce the probability of renal failure.

Dr. Fu Zhiyan said that at present, this AI prediction model can only predict whether CKD will deteriorate further. At the same time, Synapxe is studying how to use this type of AI disease prediction model for other chronic diseases.

Research results on the AI prediction model have also been published in academic journal Frontiers back in January this year.

Early prediction of chronic diseases and measures to prevent them

Dr Alan Wong, a family doctor at Vitacare Family Clinic, said that with ageing population, general practitioners are seeing more patients with chronic diseases in their daily work, and one common chronic disease would be CKD. He said that AI tools that can help identify or predict diseases can help family doctors like him who provide medical services on the front line with decision-making during consultations and provide guidance for treatment planning.

Jacob Ho, 54, chose to retire early 3 years ago from his high-pressure sales job to focus on treating his CKD. Ho developed diabetes in 1999 and was diagnosed with CKD in 2019. At that time, it became clear to him that he had to make a drastic change in his lifestyle to prevent his condition from deteriorating.

"I started watching my diet, reading nutrition labels, and avoiding foods high in sodium and calcium. I also started exercising for at least an hour per day and looked for ways to reduce stress."

Ho's health condition gradually improved, but he highlighted that had he known that diabetes would lead to a high risk of CKD, he would have made changes from the beginning.

"For those who are going through the same situation, don't give up, keep working hard, nothing is difficult if you set your mind to it."


新联科技用人工智能 测慢性肾病恶化风险

本地有超过40万名糖尿病患者,而慢性肾病是最常见的并发症之一。卫生部属下医疗科技机构新联科技,研发出一套人工智能系统,用以推算有糖尿病的慢性肾病患者,未来五年病情恶化风险,以协助医生更好地为病人提供建议,包括接受早期介入治疗,管控病情。

糖尿病是导致慢性肾病(chronic kidney disease,简称CKD)的常见原因之一。慢性肾病会让患者肾脏功能逐渐丧失,但早期阶段症状并不明显。慢性肾病一旦发展至末期肾功能衰竭,要靠洗肾或肾脏移植,才能保命。有数据显示,多达三分之二的肾衰竭因糖尿病导致。

慢性肾病共分五个阶段,新联科技(Synapxe)研发的首个全国范围糖尿病患者慢性肾病预测模型,使用了全国糖尿病数据库内,患有第一及第二期慢性肾病者的数据,用以分析他们日后是否会变成第三期及以上,病情更严重的患者。 

人工智能预测模型,会分析各项数据包括患者年龄、性别、用药记录和血液检测结果后,将患者列为三大类,即低风险、高风险,以及极高风险。

新联科技数据分析和人工智能首席专家符志彦博士受访时说,有关预测模型已在国家电子健康记录系统上使用。医生可从系统上看到病人的风险类别,再给予进一步建议。一般而言,低风险患者仅需持续观察。

新联科技数据分析和人工智能高级首席专家吴汉良博士强调,在收集数据和设计模型过程中,他们不断与临床医生沟通,从中获取反馈和再修改,确保可有效使用,“取得医生信心至关重要”。

这两名参与研究的人工智能专家说,研究旨在为医生提供辅助工具,协助做出医疗决定。有数据显示,通过早期介入医疗计划,可有助减缓病人慢性肾病恶化速度。

这个获得卫生部认可的临床模型,已被纳入全面延缓肾脏病计划(Holistic Approach in Lowering and Tracking Chronic Kidney Disease,简称HALT-CKD)。

卫生部在2017年推出全面延缓肾脏病计划,以进行肾功能检查、服用保护肾功能药物等方式,让病情管控得当者,减缓慢性肾病恶化速度,降低肾功能衰退概率。

符志彦说,目前这款人工智能预测模型,仅能预测慢性肾病是否会恶化。不过新联科技正研究,将这类人工智能预测疾病的方法,用在其他慢性疾病上。

有关人工智能预测模型的研究成果,也在今年1月刊登在《前沿》(Frontiers)学术期刊上。

提早预测慢性疾病 可采措施预防

维康医疗诊所家庭医生黄敦铭说,随着社会人口老龄化,全科医生在日常工作中,也接诊更多有慢性疾病的患者,而慢性肾病正是常见的慢性疾病之一。

他说,能够帮助识别或预测疾病的人工智能工具,可帮助像他一样在第一线提供医疗服务的家庭医生,在会诊期间做出决策,和在拟定治疗方案时给予指引。

现年54岁的何子强因高压的销售工作,选择在三年前提早退休,以专注在治疗慢性肾病。何子强在1999年患上糖尿病,2019年又确诊慢性肾病,他当时清楚意识到,要彻底改变生活方式,以防病情恶化。

“我开始注意饮食,阅读营养标签,避免食用钠和钙含量高的食物。我还开始每天锻炼至少一个小时,和想办法减轻压力。”

何子强的健康状况渐好转,但他指出,如果早知道糖尿病会导致很高的慢性肾病风险,会从一开始就做出改变。

“那些正在经历同样情况的人,不要放弃,继续努力,天下无难事,只怕有心人。”

Source: Lianhe Zaobao © Singapore Press Holdings Limited | Reproduced with permission.

 

Related articles

X

By continuing to use and navigate this website, you consent to the use of cookies in accordance with our Privacy Policy.

Confirm